REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Thailand targets vaccination of 19 mln people in first phase

Wed, 27th Jan 2021 10:12

(Recasts with vaccination plans)

By Panarat Thepgumpanat and Chayut Setboonsarng

BANGKOK, Jan 27 (Reuters) - Thailand is targeting the
immunisation of 19 million people against the coronavirus in a
first phase of inoculations starting on Feb. 14, the prime
minister said on Wednesday, amid criticism the government has
been slow in rolling out vaccines.

Inoculations will begin with 50,000 doses of AstraZeneca's
vaccine, Prayuth Chan-ocha said. He gave no timeline for
the first phase.

By May, Thailand will have received 150,000 doses from
AstraZeneca.

In a broadcast carried on the government's website, Prayuth
apologised for not solving COVID-19 related problems as fast as
the public had demanded.

"Blaming each other will not solve any problems," he said.

Of the 19 million to be vaccinated, 11 million would be
people aged over 60 and 6.1 million would be those with
underlying diseases, he said.

Another 1.7 million would be for medical professionals and
15,000 government workers involved in managing the virus, he
said, adding those under 18 and pregnant women would not be
vaccinated. About a fifth of Thailand's population is under 18.

The timeframe would depend on the capacity of hospitals
administering the vaccines and number of doses they receive,
head of the government's vaccine management committee, Sophon
Mekthon, told Reuters.

Thailand has altogether secured 26 million doses from
AstraZeneca to be produced by local firm Siam Biosience and 2
million doses from China's Sinovac. It has also reserved
35 million doses from AstraZeneca.

Thailand will initially import the vaccines but is expected
by June to be producing it locally, Sophon added.

Authorities say they will vaccinate 31.5 million people.

The education ministry on Wednesday said it would reopen
most schools from next week, in response to localised declines
in new coronavirus infections.

The announcement comes despite the country reporting on
Wednesday its second-highest number of new daily coronavirus
cases, with 819 infections, the majority due to mass testing in
Samut Sakhon province, the epicentre of the most recent
outbreak.

Thailand has reported 15,465 cases and 76 deaths.
(Reporting by Chayut Setboonsarng and
Panarat Thepgumpanat; Editing by Martin Petty and Angus MacSwan)

More News
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.